Theracryf (TCF)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

0.24p
   
  • Change Today:
      0.005p
  • 52 Week High: 1.22
  • 52 Week Low: 0.20
  • Currency: UK Pounds
  • Shares Issued: 2,148.96m
  • Volume: 58,427,356
  • Market Cap: £5.16m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
33.49% above the market average33.49% above the market average33.49% above the market average33.49% above the market average33.49% above the market average
67.57% above the sector average67.57% above the sector average67.57% above the sector average67.57% above the sector average67.57% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
64.64% below the market average64.64% below the market average64.64% below the market average64.64% below the market average64.64% below the market average
51.11% below the sector average51.11% below the sector average51.11% below the sector average51.11% below the sector average51.11% below the sector average
Price Chg 3m
10.73% above the market average10.73% above the market average10.73% above the market average10.73% above the market average10.73% above the market average
20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average20.00% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
25.55% below the market average25.55% below the market average25.55% below the market average25.55% below the market average25.55% below the market average
46.34% below the sector average46.34% below the sector average46.34% below the sector average46.34% below the sector average46.34% below the sector average
Momentum 20
11.96% below the market average11.96% below the market average11.96% below the market average11.96% below the market average11.96% below the market average
21.95% below the sector average21.95% below the sector average21.95% below the sector average21.95% below the sector average21.95% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
44.02% below the market average44.02% below the market average44.02% below the market average44.02% below the market average44.02% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
56.43% below the market average56.43% below the market average56.43% below the market average56.43% below the market average56.43% below the market average
27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average27.27% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
49.06% below the market average49.06% below the market average49.06% below the market average49.06% below the market average49.06% below the market average
12.2% below the sector average12.2% below the sector average12.2% below the sector average12.2% below the sector average12.2% below the sector average
Cash
42.18% below the market average42.18% below the market average42.18% below the market average42.18% below the market average42.18% below the market average
25.58% below the sector average25.58% below the sector average25.58% below the sector average25.58% below the sector average25.58% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y Not Available

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Theracryf Market Data

Currency UK Pounds
Share Price 0.24p
Change Today 0.005p
% Change 2.13 %
52 Week High 1.22
52 Week Low 0.20
Volume 58,427,356
Shares Issued 2,148.96m
Market Cap £5.16m

Theracryf Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
8.76% above the market average8.76% above the market average8.76% above the market average8.76% above the market average8.76% above the market average
81.40% above the sector average81.40% above the sector average81.40% above the sector average81.40% above the sector average81.40% above the sector average
Price Trend
78.53% below the market average78.53% below the market average78.53% below the market average78.53% below the market average78.53% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth Not Available

Theracryf Dividends

No dividends found

Trades for 01-Aug-2025

Time Volume / Share Price
15:49 16,284 @ 0.25p
15:47 2,020,000 @ 0.25p
15:37 115,000 @ 0.24p
12:53 114,613 @ 0.24p
12:03 1,500,000 @ 0.25p

Theracryf Key Personnel

CEO Huw Jones
CFO Toni Hänninen

Top of Page